132 related articles for article (PubMed ID: 7541665)
1. Isolation of small, primitive human hematopoietic stem cells: distribution of cell surface cytokine receptors and growth in SCID-Hu mice.
Wagner JE; Collins D; Fuller S; Schain LR; Berson AE; Almici C; Hall MA; Chen KE; Okarma TB; Lebkowski JS
Blood; 1995 Jul; 86(2):512-23. PubMed ID: 7541665
[TBL] [Abstract][Full Text] [Related]
2. Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: requirement for cell-to-cell interactions and colony-stimulating factors.
Davis TA; Robinson DH; Lee KP; Kessler SW
Blood; 1995 Apr; 85(7):1751-61. PubMed ID: 7535587
[TBL] [Abstract][Full Text] [Related]
3. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
4. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.
Brugger W; Möcklin W; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
Blood; 1993 May; 81(10):2579-84. PubMed ID: 7683923
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells, and the generation of colony-forming cell progeny from CD34+lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor.
Bernstein ID; Andrews RG; Zsebo KM
Blood; 1991 Jun; 77(11):2316-21. PubMed ID: 1710148
[TBL] [Abstract][Full Text] [Related]
8. In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells.
Tong J; Gordon MS; Srour EF; Cooper RJ; Orazi A; McNiece I; Hoffman R
Blood; 1993 Aug; 82(3):784-91. PubMed ID: 7687893
[TBL] [Abstract][Full Text] [Related]
9. CD64/Fc gamma RI is a granulo-monocytic lineage marker on CD34+ hematopoietic progenitor cells.
Olweus J; Lund-Johansen F; Terstappen LW
Blood; 1995 May; 85(9):2402-13. PubMed ID: 7537112
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
[TBL] [Abstract][Full Text] [Related]
11. Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells.
Broxmeyer HE; Cooper S; Lu L; Hangoc G; Anderson D; Cosman D; Lyman SD; Williams DE
Blood; 1991 May; 77(10):2142-9. PubMed ID: 1709371
[TBL] [Abstract][Full Text] [Related]
12. Effects of mast cell growth factor, interleukin-3, and interleukin-6 on human primitive hematopoietic progenitors from bone marrow and cord blood.
Tsujino Y; Wada H; Misawa M; Kai S; Hara H
Exp Hematol; 1993 Sep; 21(10):1379-86. PubMed ID: 7689484
[TBL] [Abstract][Full Text] [Related]
13. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
Traycoff CM; Abboud MR; Laver J; Clapp DW; Srour EF
Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
[TBL] [Abstract][Full Text] [Related]
14. Further phenotypic characterization and isolation of human hematopoietic progenitor cells using a monoclonal antibody to the c-kit receptor.
Briddell RA; Broudy VC; Bruno E; Brandt JE; Srour EF; Hoffman R
Blood; 1992 Jun; 79(12):3159-67. PubMed ID: 1375842
[TBL] [Abstract][Full Text] [Related]
15. CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.
Verfaillie CM; Miller JS
Blood; 1994 Sep; 84(5):1442-9. PubMed ID: 7520771
[TBL] [Abstract][Full Text] [Related]
16. Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells.
Brandt JE; Bhalla K; Hoffman R
Blood; 1994 Mar; 83(6):1507-14. PubMed ID: 7510143
[TBL] [Abstract][Full Text] [Related]
17. Proliferative responses to interleukin-3 and granulocyte colony-stimulating factor distinguish a minor subpopulation of CD34-positive marrow progenitors that do not express CD33 and a novel antigen, 7B9.
Litzow MR; Brashem-Stein C; Andrews RG; Bernstein ID
Blood; 1991 Jun; 77(11):2354-9. PubMed ID: 1710150
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
[TBL] [Abstract][Full Text] [Related]
19. Delineation of T-progenitor cell activity within the CD34+ compartment of adult bone marrow.
Galy AH; Cen D; Travis M; Chen S; Chen BP
Blood; 1995 May; 85(10):2770-8. PubMed ID: 7537981
[TBL] [Abstract][Full Text] [Related]
20. Synergistic actions of stem cell factor and other burst-promoting activities on proliferation of CD34+ highly purified blood progenitors expressing HLA-DR or different levels of c-kit protein.
Sonoda Y; Sakabe H; Ohmisono Y; Tanimukai S; Yokota S; Nakagawa S; Clark SC; Abe T
Blood; 1994 Dec; 84(12):4099-106. PubMed ID: 7527665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
